Related Experiment Videos
Insights
Gout, a metabolic disease, is increasingly prevalent, often accompanied by kidney damage, hypertension, and heart issues. Its management requires consideration of age-related factors and the patient's overall clinical condition.
Area of Science:
- Metabolic disorders
- Clinical medicine
- Epidemiology
Context:
- Increasing prevalence of gout in the GDR since the 1960s.
- Gout as a metabolic disease with significant comorbidities.
- Documented associations between hyperuricemia and other metabolic conditions.
Purpose:
- To highlight the growing importance and multifaceted nature of gout.
- To outline the common accompanying phenomena and related conditions of gout.
- To emphasize the influence of age and clinical status on gout management.
Summary:
- Gout's rising incidence is linked to metabolic disturbances.
- Associated conditions include renal lesions, hypertension, cardiac, and peripheral arterial diseases.
- Hyperuricemia correlates with obesity, hyperlipoproteinemia, diabetes mellitus, and fatty liver disease.
- Age-specific characteristics and clinical state dictate gout treatment strategies.
Impact:
- Underscores the need for comprehensive management of gout and its associated metabolic risks.
- Informs clinical practice regarding the systemic impact of gout.
- Highlights the public health significance of metabolic syndrome components related to gout.
Abstract:
The importance of the gout is growing in the GDR as its frequency has been increasing since the sixties. The gout is a disease of metabolism with the following accompanying phenomena: renal lesion in gout, hypertension, cardiac diseases and peripheral arterial diseases. Besides, there are proved relations between hyperuricemia and obesity, hyperlipoproteinemia, diabetes mellitus as well as steatosis hepatis. In describing the nature of the gout the peculiarities of age are stressed. The treatment of the gout depends on the clinical state.